According to a new study published in the journal Stroke, more than two-fifths of elderly patients with atrial fibrillation (a type of abnormal heart rhythm) are not using the blood-thinner warfarin, an anticoagulant commonly known by the trade name Coumadin. This drug is prescribed to prevent strokes associated with clots in the atria, the upper heart chambers. These can become emboli, or clots that travel to the brain.
According to a new study published in the journal Stroke, more than two-fifths of elderly patients with atrial fibrillation (a type of abnormal heart rhythm) are not using the blood-thinner warfarin, an anticoagulant commonly known by the trade name Coumadin. This drug is prescribed to prevent strokes associated with clots in the atria, the upper heart chambers. These can become emboli, or clots that travel to the brain.